If 340B did not exist, drug companies would have an extra $6 billion in their pocket.
Editor's note · Context
Warren argues that the 340B Program's discounts are minimal compared to drug companies' profits.
Share
More from Elizabeth Warren
Without greater visibility into these acquisitions, it is not just national security that could be on the line — Americans’ access to medicines is also at risk.
That is a clear conflict of interest. And yet, DOD actually requires the TRICARE pharmacy contractor to own both a PBM and a pharmacy. I don’t know who talked them into that, but it is an open invitation for Express Scripts to milk the…
I urge DOD to flatly prohibit vertical integration in the next TRICARE pharmacy contract. A vertically integrated PBM has every incentive to line its own pockets, and DOD should not be using taxpayer dollars to fund these schemes.
I’m pretty outraged that you drag in billions of dollars from taxpayers and that you won’t submit to an audit when it’s clear that you have the opportunity to bilk the federal government and you have used that opportunity in other…





